Cargando…

Entecavir/interferon-α-2b/methylprednisolone: Hepatitis B viral reactivation and off label use: case report

Detalles Bibliográficos
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer International Publishing 2021
Materias:	Case Report
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8350292/ http://dx.doi.org/10.1007/s40278-021-00233-7

Ejemplares similares

Tocilizumab: Hepatitis-B viral reactivation with acute hepatitis following an off-label treatment: case report
Publicado: (2021)

Methylprednisolone/tocilizumab: Hepatotoxicity, cytomegalovirus reactivation and off label use: 2 case reports
Publicado: (2021)

Methylprednisolone/prednisone: Accelerated viral replication following an off-label treatment: case report
Publicado: (2020)

Methylprednisolone/prednisolone: Delayed viral clearance and off label use: 2 case reports
Publicado: (2020)

Hydroxychloroquine/methylprednisolone/nafamostat: Delayed viral clearance and off label use: case report
Publicado: (2021)

Enoxaparin sodium/methylprednisolone: Cytomegalovirus reactivation, gastrointestinal haemorrhage and off-label use: case report
Publicado: (2020)

Methylprednisolone: Bacteraemia following off label use: case report
Publicado: (2021)

Methylprednisolone: Worsening hyperglycaemia and off-label use: case report
Publicado: (2021)

Methylprednisolone: Strongyloidiasis following off-label treatment: case report
Publicado: (2022)

Methylprednisolone: Fungaemia following an off-label use: case report
Publicado: (2022)

Azithromycin/methylprednisolone: Hyperglycaemia following off label use: case report
Publicado: (2020)

Methylprednisolone/tocilizumab: Disseminated strongyloidiasis and off-label use: case report
Publicado: (2020)

Methylprednisolone/remdesivir: Lack of efficacy and off-label use: case report
Publicado: (2021)

Dexamethasone/methylprednisolone: Off label use and lack of efficacy: case report
Publicado: (2022)

Dexamethasone/methylprednisolone: Off-label use and cryptococcal meningoencephalitis: case report
Publicado: (2022)

Methylprednisolone: Lack of efficacy following off-label use: case report
Publicado: (2022)

Methylprednisolone: Opportunistic infections and off-label-use: 5 case reports
Publicado: (2021)

Favipiravir/methylprednisolone: Off-label use and lack of efficacy: case report
Publicado: (2022)

Entecavir to Telbivudine Switch Therapy in Entecavir-Treated Patients with Undetectable Hepatitis B Viral DNA
por: Kim, Dong Hyun, et al.
Publicado: (2017)

Dexamethasone/hydrocortisone/methylprednisolone: Disseminated cryptococcosis following off label use of dexamethasone, hydrocortisone and methylprednisolone: case report
Publicado: (2022)

Antivirals/interferon-α-1b: Elevated aminotransferases and vomiting following off-label use: case report
Publicado: (2021)

Hepatitis B viral breakthrough associated with inappropriate preservation of entecavir
por: Karabay, Oguz, et al.
Publicado: (2012)

Severe Acute Hepatitis B Treated With Entecavir.
por: De Socio, Giuseppe Vittorio Luigi, et al.
Publicado: (2011)

Methylprednisolone: Decrease in T cell count following off label use: case report
Publicado: (2020)

Methylprednisolone/tocilizumab: Intestinal perforation following off-label use: case report
Publicado: (2020)

Methylprednisolone/tocilizumab: Intestinal perforation following off-label use: case report
Publicado: (2021)

Methylprednisolone/tocilizumab: Gastrointestinal perforation following off label use: case report
Publicado: (2021)

Azithromycin/dexamethasone/methylprednisolone: Aspergillosis, mucormycosis and off-label use: case report
Publicado: (2022)

Methylprednisolone/tocilizumab: Cytomegalovirus gastritis following off label use: case report
Publicado: (2022)

Methylprednisolone: Rhino-facial mucormycosis following off label use: case report
Publicado: (2022)

Methylprednisolone/umifenovir interaction: Sinus bradycardia and off label use: case report
Publicado: (2022)

Methylprednisolone/tocilizumab: Lack of efficacy in off-label use: 7 case reports
Publicado: (2021)

Dexamethasone/methylprednisolone/remdesivir: Off-label use and lack of efficacy: case report
Publicado: (2021)

Glucocorticoids/siltuximab/tocilizumab: Hepatitis-B reactivation following off-label use: 2 case reports
Publicado: (2021)

Hepatitis B surface antigen titer is a good indicator of durable viral response after entecavir off-treatment for chronic hepatitis B
por: Lee, Han Ah, et al.
Publicado: (2016)

Amphotericin-B-liposomal/dexamethasone/methylprednisolone: Invasive candida kefyr infection, off label use and drug resistance: case report
Publicado: (2022)

Dupilumab in patients with chronic hepatitis B on concomitant entecavir
por: Ly, Karen, et al.
Publicado: (2019)

Efficacy of an Inhibitor of Hepatitis B Virus Expression in Combination With Entecavir and Interferon‐α in Woodchucks Chronically Infected With Woodchuck Hepatitis Virus
por: Menne, Stephan, et al.
Publicado: (2020)

Hydrocortisone/methylprednisolone/tocilizumab: Various toxicities following off-label treatment: case report
Publicado: (2021)

Antibacterials/immune-globulin/methylprednisolone: Lack of efficacy and off label use: case report
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_ggfn3g3kp21h1v5josfcng1vea